CONNECT WITH US
HealthTech

HealthTech

Medtronic names Felicia Kurz as cardiac ablation VP, GM

MedTech Dive logo

Published on

Add as a preferred source on Google
Medtronic names Felicia Kurz as cardiac ablation VP, GM

Kurz’s appointment comes as Medtronic enjoys strong growth in electrophysiology therapies thanks to demand for its pulsed field ablation devices.

New title: Vice president and general manager of cardiac ablation solutions, Medtronic

Felicia Kurz is the new vice president and general manager of the cardiac ablation solutions business at Medtronic.

A Medtronic spokesperson confirmed the appointment, which was first announced on LinkedIn by Rebecca Seidel, Medtronic’s president of electrophysiology therapies. Cardiac ablation solutions is one of several businesses within the electrophysiology therapies division at Medtronic.

Kurz joined Medtronic following a decade at Siemens Healthineers, where she most recently was senior vice president and head of advanced therapies for North America, according to her LinkedIn profile. The business included angiography, hemodynamics and mobile imaging equipment. Before that, she was Siemens Healthineers’ head of strategy and business development for the Americas.

“Felicia joins us with an impressive track record of leadership and innovation in healthcare,” Seidel said in her LinkedIn post. “Her experience spans commercial, strategy, business development, and global team leadership, making her exceptionally well positioned for this next chapter.”

Seidel previously was Medtronic’s president of cardiac ablation solutions, before being named president of electrophysiology therapies in June, according to her LinkedIn profile.

Medtronic recently reorganized its cardiovascular portfolio into four divisions: electrophysiology therapies, interventional cardiology therapies, cardiovascular surgery and peripheral vascular health. 93 billion, up nearly 20% year over year, in Medtronic’s fiscal first quarter. Cardiac ablation solutions revenue surged 88% on demand for the company’s pulsed field ablation devices.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.